Deep Tech Startups

Morphotonics develops large-area nanoimprint lithography technology, combining hardware, processes, and proprietary materials to replicate sub-100 nm features across square-meter surfaces at high volume. Its solutions serve consumer electronics makers producing nano-optics for AR/AI smart glasses and microtextures for 3D and anti-glare display screens.

2 investors

MotionLab.Berlin is an innovation hub and makerspace offering professional labs, a community, and programs for hardtech founders, engineers, and creatives to develop and commercialize technology. Based in Berlin, it supports entrepreneurship in hardtech, art, and creativity.

2 investors

MQS builds Cebule, a platform combining quantum chemistry calculations and machine learning pipelines to predict molecular properties and design experiments for R&D teams. It offers a visual dashboard over 200M+ molecules, a Python SDK, HPC compute nodes, and an AI research agent serving biopharmaceutical, materials, and chemistry researchers in academia and industry.

2 investors

MSTRO operates a network called Living Intelligence that adds responsive, data-driven capabilities to physical venues such as stadiums, racetracks, hospitals, airports, and city districts without requiring operators to become data companies. It offers venue subscriptions, an RDK for third-party vendors to build connector packs, and geofence-based virtual venue tiers, with a privacy architecture that holds no personal guest records.

2 investors

Multibeam develops a multicolumn electron-beam lithography platform for semiconductor manufacturing. The platform serves device makers and chipmakers for advanced packaging, photonics, quantum devices, MEMS, sensors, and other specialized semiconductor applications.

2 investors

Muon Vision uses cosmic ray muons to provide 4D continuous subsurface monitoring, delivering volumetric scan data on heap leach pads, tailings dams, and underground assets. It serves mining operators looking to boost metal recovery, manage slope and dam stability, and detect ore bodies or geohazards.

2 investors

Mycel is a blockchain infrastructure for cross-chain asset exchange, using an Ownership Transfer Protocol (OTP) and a CometBFT-based consensus layer (HyphaBFT) to swap native tokens across isolated blockchain ecosystems. It offers orderbook-based matchmaking and threshold signature security aimed at unifying fragmented liquidity across chains.

2 investors

Mynvax develops engineered protein subunit vaccines using a protein stabilization platform, including influenza vaccine candidates based on stabilized hemagglutinin regions and thermo-tolerant vaccines against SARS-CoV-2 variants. Incubated at the Indian Institute of Science, the biotech startup collaborates with research labs, CDMOs, and vaccine manufacturers, with some programs funded by Indian government agencies.

2 investors

MythWorx develops neuromorphic and generative AI systems that run efficiently on standard CPUs and edge devices, targeting robotics, defense, manufacturing, healthcare, and IoT applications. The platform combines brain-inspired architectures with generative modeling to deliver reasoning and decision-making without the computational overhead of traditional large language models.

2 investors

n-hop technologies develops BATS, a network coding technology based on research at The Chinese University of Hong Kong that maintains transmission throughput across many hops in lossy multi-hop networks over any physical layer (wireless, satellite, underwater, powerline). It targets applications such as 5G access networks, smart lampposts, rural internet, CCTV networks, IoT, V2X, and satellite communications.

2 investors

Number Zero is an open R&D organization building software for efficient distributed systems, including iroh, a toolkit for building distributed applications. Its products create direct, low-resource networking connections between devices for reliable data sync and transfer even with unstable connectivity.

2 investors

Nabhdrishti Aerospace develops indigenous micro gas turbines, including its ND 400 (400 N) fuel-flexible engine, for use in aviation (UAVs, hybrid-electric flight, small planes and helicopters) and distributed power generation. The India-based company designs a single core engine architecture for dual use across propulsion and power applications, aiming for higher efficiency and lower cost than competing turbines.

2 investors

NaDeNo develops nanoparticle-based drug delivery technology for local, targeted and controlled release of hard-to-deliver molecules, and offers its platform to pharma and biotech companies. Its lead asset, PACAB-002, is a therapeutic designed to prevent recurrence in high-grade serous ovarian cancer by eradicating residual peritoneal micrometastases, with a Phase 1 trial planned for early 2027.

2 investors

Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.

2 investors

NanoQT (Nanofiber Quantum Technologies) develops quantum interconnect hardware based on a proprietary ultra-low-loss nanofiber cavity that uses cavity quantum electrodynamics to link quantum processing units via photons. Its technology targets neutral-atom quantum computing and networked, modular quantum systems, aiming to enable scalable quantum computing and secure quantum communication.

2 investors

NanoBioFab develops AI-powered nanosensor technology for rapid, non-invasive detection of pathogens through their gaseous signatures in clinical settings. The technology targets hospitals and enterprise healthcare systems for applications in orthopedics, wound care, urology, and pulmonology.

2 investors

Nanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.

2 investors

Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.

2 investors

Nanocrine develops nanoplasmonic biosensor chips that let cell biology researchers image protein secretions from living cells in real time, without labels, using standard live-cell microscopes. Its single-use biochips apply surface plasmon resonance sensing to map extracellular secretions spatially, functioning like a real-time, microscope-based ELISA.

2 investors

Nanode Battery Technologies develops alloy-based anode materials for sodium-ion batteries, aiming to deliver high-energy-density, fast-charging cells through low-cost, eco-friendly manufacturing methods. The company positions its battery materials for use in customer projects requiring efficient and affordable energy storage.

2 investors

Nanome provides a conversational, AI-assisted platform for exploring molecular structures across web and XR, letting researchers load, build, edit, and score structures using natural language and 300+ scientific tools. It is aimed at pharmaceutical and chemistry R&D teams working with 3D molecular data.

2 investors

Nanomox develops advanced materials and thin films, such as metal oxide particles ranging from nano to macro scale, using fine control of particle properties for a range of applications. The company positions its materials as more efficient than conventional ones for improving existing products and developing new ones.

2 investors

Nanopattern Technologies is a company focused on nanopatterning, with a team including chemists, researchers, and engineers working on materials and related technology.

2 investors

Nanophage Technologies develops nanorod-based scaffold technology designed to amplify the signal of detection molecules for improved diagnostic or sensing applications. The company is built around a scientific team focused on this nanotechnology.

2 investors